| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss | ||||||
-32,900 | -23,138 | -29,727 | ||||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Depreciation expense | ||||||
47 | 49 | 48 | ||||
Change in right of use assets. | ||||||
729 | - | - | ||||
Stock-based compensation expense | ||||||
3,732 | 3,469 | 5,600 | ||||
Change in fair value of restricted stock liability | ||||||
159 | - | - | ||||
Non-cash interest expense - related party | ||||||
- | - | 121 | ||||
Change in fair value of warrant liability | ||||||
- | -7,284 | -473 | ||||
Changes in operating assets and liabilities: | ||||||
Prepaid expenses and other assets | ||||||
-302 | 297 | 99 | ||||
Deferred tax assets | ||||||
3 | -20 | 158 | ||||
Research and development incentive receivable | ||||||
-643 | -780 | -1,458 | ||||
Accounts payable and accrued expenses | ||||||
1,084 | 368 | - | ||||
Accounts payable and accrued expenses | ||||||
- | - | 1,093 | ||||
Lease liability | ||||||
-695 | - | - | ||||
Net cash used in operating activities | ||||||
-26,902 | -26,033 | -22,137 | ||||
Purchases of property and equipment | ||||||
100 | - | 64 | ||||
Proceeds from sale of property and equipment | ||||||
15 | - | - | ||||
Net cash used in investing activities | ||||||
-85 | - | -64 | ||||
Proceeds from issuance of common stock in connection with merger with Macrocure | ||||||
- | - | 21,165 | ||||
Proceeds from issuance of common stock | ||||||
- | - | 10,000 | ||||
Proceeds from issuance of common stock in connection with Private Placement | ||||||
- | - | 18,000 | ||||
Proceeds from the issuance of common stock, net of underwriter commissions and discounts | ||||||
12,331 | 15,034 | - | ||||
Proceeds from issuance of common stock from ATM sales | ||||||
1,923 | - | - | ||||
Proceeds from issuance of common stock in connection with July 2019 Lincoln Park Capital Registered Offering Purchase Agreement | ||||||
1,000 | - | - | ||||
Proceeds from notes payable - related party | ||||||
- | - | 750 | ||||
Proceeds from the exercise of common stock warrants | ||||||
- | 1,217 | - | ||||
Proceeds from the exercise of stock options | ||||||
- | 14 | 20 | ||||
Payment of deferred offering costs | ||||||
437 | 359 | 2,172 | ||||
Net cash provided by financing activities | ||||||
14,817 | 15,906 | 47,763 | ||||
Effect of exchange rate changes on cash and cash equivalents | ||||||
-223 | 674 | -618 | ||||
Net increase in cash and cash equivalents | ||||||
-12,393 | -9,453 | 24,944 | ||||
Supplemental disclosure of non-cash financing activities: | ||||||
Accretion of preferred stock to redemption value | ||||||
- | - | 244 | ||||
Reduction in fair value of warrant liability as a result of exercise of common stock warrants | ||||||
- | 1,130 | - | ||||
Reclassification of 2017 Warrants from liability to equity | ||||||
3,448 | - | - | ||||
Dividend attributable to down round feature of warrants | ||||||
359 | - | - | ||||
Offering costs included in accounts payable and accrued expenses | ||||||
444 | 41 | 131 | ||||
Right-of-use asset recorded upon adoption of ASU 2016-02 | ||||||
1,755 | - | - | ||||
Lease liability recorded upon adoption of ASU 2016-02 | ||||||
1,720 | - | - | ||||
Accrued rent reclassified upon adoption of ASU 2016-02 | ||||||
35 | - | - | ||||
Conversion of notes payable-related party and accrued interest convertible preferred stock into common stock | ||||||
- | - | 31,145 | ||||
Conversion of convertible preferred stock into common stock | ||||||
- | - | 70,775 | ||||
Value of net assets acquired in connection with merger with Macrocure, excluding cash | ||||||
- | - | 96 | ||||